Like serum levels, hepatic IGF-1 mRNA levels also decline with increasing degrees of steatosis, steatohepatitis, and fibrosis in adults [28,83], whereas IGF-1R and GHR expression does not appear to change with increasing severity of NAFLD [28]. The gene discussed is IGF1; the disease is metabolic dysfunction-associated steatotic liver disease.